Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Treatment.Com International Inc. (TREIF)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0540-0.0172 (-24.21%)
At close: 01:37PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0712
Open0.0744
BidN/A x N/A
AskN/A x N/A
Day's Range0.0540 - 0.0744
52 Week Range0.0445 - 1.0000
Volume2,072
Avg. Volume6,355
Market Cap3.718M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1650
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for TREIF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • TREATMENT COM INTL INC
    Analyst Report: VMware, Inc.VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses; subscriptions and software as a service; and services. VMware’s solutions are used across IT infrastructure, application development, and cybersecurity teams, and the company takes a neutral approach to being the cohesion between cloud environments. The Palo Alto, California, firm operates and sells on a global scale, with about half its revenue from the United States, through direct sales, distributors, and partnerships.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • GlobeNewswire

    Treatment’s Debut AI-driven Health App Getting Five Star Reviews from Doctors

    VANCOUVER, British Columbia, April 06, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), is a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. Treatment’s landmark debut product, the Treatment Digital Health App, has been garnering five-star reviews on both the Apple App Store and the Google Play Store. Users’ comments

  • GlobeNewswire

    Treatment Announces Convertible Debenture Private Placement

    VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment or the “Company”) (CSE: TRUE; OTC: TREIF; FFA: 939), a global healthcare company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions, announces the proceeding of a non-brokered private placement, raising aggregate gross proceeds of up to $1,250,000 in unsecured convertible debentures (the “Private Placement”). Each

  • GlobeNewswire

    Treatment’s Doctor-Built Digital Health App now on Google Play Store

    VANCOUVER, British Columbia, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Treatment.com International Inc. (“Treatment” or the “Company”) (CSE: TRUE; OTC: TREIF; FFA 939) is a global healthcare technology company that has developed a next-generation AI platform to help patients and caregivers around the world make better health decisions. After a successful launch on the Apple App Store, Treatment’s revolutionary symptom assessment tool, Treatment Digital Health App, is now available to millions more smart

Advertisement
Advertisement